EUVIMEDEUVIMED entdecken
Open Access

Tuning Helical Peptide Nanofibers as a Sublingual Vaccine Platform for a Variety of Peptide Epitopes

Emily F Roe, Helena Freire Haddad, Kat M Lazar, Peiying Liu, Joel H Collier iD

Advanced Healthcare Materials · 2025-01 · 14 (3)

DOI: 10.1002/adhm.202402055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.12.2024. Verfasst von Emily F Roe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA. Hauptthemen laut MEDLINE: Nanofibers, Epitopes, Peptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Science Foundation, North Carolina Biotechnology Center, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal immune responses to vaccination are essential for achieving full protection against pathogens entering their host at mucosal sites. However, traditional parenteral immunization routes commonly fail to raise significant mucosal immunity. Sublingual immunization is a promising alternative delivery route to raise robust immune responses both systemically and at mucosal sites, and nanomaterial‐based subunit vaccine platforms offer opportunities for raising epitope‐specific responses. Here, sublingual immunization is reported using the Coil29 platform of coiled‐coil self‐assembling peptide nanofibers. The successful immunization with epitopes of varying physicochemical properties by including mucus‐modulating components – namely sequences of proline, alanine, and serine (PAS) is demonstrated. PASylation is shown to decrease mucin complexation and increase epithelial penetration in vitro, enabling sublingual immunization against a variety of selected peptide epitopes in vivo. Coil29 fibers are also readily formed into tablets for solid‐state dosing formulations and maintain their immunogenicity in this state. Previous sublingual peptide nanofiber immunotherapies have been based on different structures, such as highly stable β‐sheets. The present work demonstrates that alternatively folded structures such as α‐helical nanofibers can also be rendered sublingually immunogenic, enabling immunization with a variety of peptide epitopes and offering additional ways to specify mucus interactions, delivery state, dosing, and formulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanofibersEpitopesPeptidesAnimalsAdministration, SublingualMiceFemaleVaccines, SubunitMice, Inbred BALB C

Stichwörter der Autor:innen

biomaterialspeptideself‐assemblysublingualvaccine

Substanzen

EpitopesPeptidesVaccines, Subunit

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.

ORCID-Profile: Joel H Collier

Förderung

  • National Science Foundation
  • North Carolina Biotechnology Center
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Duke University
  • National Institutes of Health (NIH) of the United States
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Roe, E. F., Freire Haddad, H., Lazar, K. M., Liu, P., & Collier, J. H. (2025). Tuning Helical Peptide Nanofibers as a Sublingual Vaccine Platform for a Variety of Peptide Epitopes. Advanced Healthcare Materials, 14(3). https://doi.org/10.1002/adhm.202402055

Vancouver

Roe EF, Freire Haddad H, Lazar KM, Liu P, Collier JH. Tuning Helical Peptide Nanofibers as a Sublingual Vaccine Platform for a Variety of Peptide Epitopes. Advanced Healthcare Materials. 2025;14(3). doi:10.1002/adhm.202402055

BibTeX
@article{Roe2025,
  author = {Roe, Emily F and Freire Haddad, Helena and Lazar, Kat M and Liu, Peiying and Collier, Joel H},
  title = {Tuning Helical Peptide Nanofibers as a Sublingual Vaccine Platform for a Variety of Peptide Epitopes},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {3},
  doi = {10.1002/adhm.202402055}
}
Kostenlos starten →